Coronary Calcium Score Explained: What Your Number Means

The coronary calcium score — also called the calcium scoring test or coronary artery calcium (CAC) score — measures the amount of calcified plaque in your coronary arteries using a non-contrast CT scan. Calcification is a late-stage marker of atherosclerosis: as fatty plaques harden over years, the calcium they contain becomes visible on imaging. The result is expressed as an Agatston score, named after Dr Arthur Agatston of the Miami Heart Research Institute, who developed the method in 1990.

In Singapore, the test takes approximately 10 to 12 minutes. No contrast dye, no needles, no special preparation. Radiation exposure is comparable to a standard chest X-ray series — considerably less than a mammogram. A cardiologist then interprets the score alongside your full cardiovascular risk profile.

A calcium score of zero is genuinely good news — but it is worth understanding precisely what it guarantees and what it does not. The landmark Multi-Ethnic Study of Atherosclerosis (MESA), one of the largest cardiovascular cohort studies ever conducted, found that participants with CAC = 0 had event rates of less than 5% over 10 years — placing them firmly in the low-risk category regardless of traditional risk factor calculations.

Research published in JACC: Cardiovascular Imaging (2020) introduced the concept of a “warranty period”: a CAC = 0 result provides approximately 5 years of low-risk reassurance before a repeat scan is worth considering, a finding confirmed in both Western and Asian populations. However, 16-year follow-up data from MESA also confirmed that smoking, diabetes, and hypertension remain independently associated with cardiovascular events even in people with CAC = 0. A zero is a low-risk passport — not a lifetime exemption.

The Agatston scoring system divides into four clinically recognised categories:

0 (absent): No detectable calcified plaque. Very low near-term risk — less than 5% at 10 years in the MESA dataset.

1–100 (mild): Calcified plaque is present but limited. Risk is elevated compared to zero. Lifestyle modification is appropriate; the statin decision depends on the broader risk profile.

101–400 (moderate): The ACC/AHA guidelines support initiating statin therapy at this range. A CAC of 100 or above in patients under 70 also identifies individuals in whom aspirin's cardiovascular benefit outweighs its bleeding risk.

>400 (high): Significant plaque burden. High-intensity statin therapy is generally indicated; a CT coronary angiogram may be considered for symptomatic patients in Singapore.

This is the most common question we receive after a patient gets a score above zero — and the honest answer is no, not in any meaningful clinical sense. Calcium deposited in the coronary arterial wall is a structural change; it does not dissolve.

What statins do to the calcium scoring test result is actually counterintuitive — a phenomenon cardiologists call the “calcium paradox.” Research published in Arteriosclerosis, Thrombosis, and Vascular Biology and confirmed in more recent imaging studies found that statin-treated patients often show higher Agatston scores over time, not lower ones. Statins shift plaque calcium toward a denser, more crystalline form: total plaque area decreases, but the calcified proportion increases — and dense calcium is more stable and less prone to rupture than the soft lipid-rich plaque it replaces.

The goal of treatment is therefore never to lower the number on a calcium score report. The goal is to lower the risk of a heart attack — and those are not always the same thing. In Singapore as elsewhere, this distinction is worth explaining clearly to every patient who asks.

The 2023 ACC/AHA guidelines recommend considering CAC scoring for asymptomatic adults at intermediate cardiovascular risk — typically a 10-year ASCVD risk of 7.5% to 20% — where the decision to start statin therapy is genuinely uncertain. The calcium scoring test is particularly useful in two opposite situations: patients reluctant to start statins (a positive score often motivates them to begin) and patients wondering whether statins are truly necessary (a zero score can support a watchful approach).

In Singapore, patients presenting at Paragon Medical Centre in their 40s or 50s with one or two risk factors — and a traditional risk score that sits in the grey zone — frequently find that a single CAC scan settles the question. Adults with a strong family history of premature coronary artery disease are another group worth considering, regardless of their calculated risk score.

A calcium score does not stand alone — it informs a broader clinical conversation. At our clinic in Paragon Medical Centre, Orchard Road, the result is reviewed alongside the full lipid profile, blood pressure, diabetes status, family history, and lifestyle factors.

As a general guide: a score of 0 typically supports deferring statins and focusing on lifestyle, with a repeat scan in about 5 years. A score of 1–100 prompts a frank discussion about lifestyle and, depending on the full picture, a statin. A score above 100 generally supports initiating statin therapy. A score above 400 warrants high-intensity statin treatment and, for symptomatic patients in Singapore, sometimes a CT coronary angiogram to assess whether any arterial narrowing is present.

Current evidence also supports aspirin for primary prevention in adults under 70 with a CAC above 100, where the cardiovascular benefit of aspirin exceeds the bleeding risk.

Booking a calcium scoring test in Singapore is straightforward. The scan is available at the major restructured hospitals (Singapore General Hospital, National University Hospital, Tan Tock Seng Hospital) and at private cardiology clinics including Paragon Medical Centre.

There is no preparation required: no fasting, no change to medications, no contrast dye. You will lie still in a CT scanner for about 10 to 12 minutes. Results are typically available the same day or within 24 hours. Private rates in Singapore typically range from SGD 200 to SGD 400 depending on the facility. Medisave cannot generally be used for asymptomatic cardiovascular screening; some integrated shield plans may cover it, so it is worth checking with your insurer before booking.